{"id":"W4226403841","doi":"10.1007/s10637-022-01227-5","title":"Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA","year":2022,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Orphan drug; Cancer drugs; Food and drug administration; Drug approval; Clinical trial; Confidence interval; Odds ratio; Clinical research; Cancer; Family medicine; Drug; Internal medicine; Environmental health; Pharmacology; Bioinformatics","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003907308,0.0001468563,0.0004414626,0.0001309975,0.0004611999,0.00003431589,0.0002103701,0.00003855833,0.001042267],"category_scores_gemma":[0.0002802808,0.0001727504,0.00003150687,0.0002068051,0.0001419315,0.0001797098,0.0001098687,0.0002099451,0.000005572974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007376968,"about_ca_system_score_gemma":0.004236843,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8485156,"about_ca_topic_score_gemma":0.1572276,"domain_scores_codex":[0.9969241,0.0002779565,0.001889136,0.0003969308,0.0002500699,0.0002618264],"domain_scores_gemma":[0.9973102,0.0004819157,0.001629639,0.0002066986,0.00002995278,0.0003415893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000136611,0.00002388263,0.03214046,0.0001161294,0.0000716765,1.208835e-7,0.01090248,0.0002837965,0.00001098098,0.03409034,0.9210925,0.001253945],"study_design_scores_gemma":[0.003670936,0.0001968677,0.1564476,0.00007320718,0.000026503,0.00001960902,0.01080107,0.005324982,0.0001200342,0.1063759,0.7162027,0.0007404989],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6597146,0.005173057,0.000112973,0.3290957,0.0003443791,0.0006748532,0.004716927,0.00001077635,0.0001566907],"genre_scores_gemma":[0.9191026,0.0001441299,0.001668245,0.07582864,0.0003863159,0.0001898944,0.001367194,0.00003181616,0.001281176],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6912881,"threshold_uncertainty_score":0.9998709,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.148947661525033,"score_gpt":0.3762924999720464,"score_spread":0.2273448384470134,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}